| Study title | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) |
| Disease or condition | Primary Biliary Cholangitis |
| Study type | Interventional (clinical trial) |
| Intervention/treatment | Seladelpar (capsule) |
| Phase | 3 |
| Study site | Duke University |
| Study location | Durham, NC |
| Principal investigator name | Andrew Muir, MD |
| Study coordinator name and email | Christy Walters, RN christy.walters@duke.edu |
| Phone contact | 919-668-5499 |
| Clinicaltrials.gov link | https://www.clinicaltrials.gov/ct2/show/NCT03301506 |